Inactivation of the p53-homologue p73 by the mdm2-oncoprotein - PubMed (original) (raw)
. 1999 Mar 25;18(12):2101-6.
doi: 10.1038/sj.onc.1202512.
Affiliations
- PMID: 10321734
- DOI: 10.1038/sj.onc.1202512
Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
M Dobbelstein et al. Oncogene. 1999.
Abstract
The p73beta protein shares structural and functional similarities with the tumor suppressor gene product p53. Both proteins activate transcription from p53-responsive promoters. p53's activity is antagonized by the mdm2 protein (also termed hdm2 in human cells). Complex formation between p53 and mdm2 results in p53's transcriptional inactivation and destabilization. Here we show that overexpression of mdm2 reduces p73beta's ability to activate transcription, too. The mdm2 protein forms a specific complex with p73beta in vitro with an efficiency comparable to p53-binding. Further, both p73beta and p53 relocalize a transport-defective mutant of mdm2 from the cytoplasm to the nucleus, arguing that complex formation occurs in vivo as well. Mutational analysis suggests that the interaction between p73beta and mdm2 follows structural principles analogous to the p53-mdm2-complex. Whereas p53 is destabilized in the presence of mdm2, the amount of intracellular p73beta was not detectably reduced by mdm2. The carboxyterminal RING finger domain of mdm2 was found to be required to reduce the intracellular abundance of p53, but it was dispensable for transcriptionally inactivating either p53 or p73beta. Our results suggest that the autoregulatory feedback loop between p53 and mdm2 also controls p73's activity, but that mdm2-mediated protein degradation is unique to p53.
Similar articles
- MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin WG Jr, Oren M, Chen J, Lu H. Zeng X, et al. Mol Cell Biol. 1999 May;19(5):3257-66. doi: 10.1128/MCB.19.5.3257. Mol Cell Biol. 1999. PMID: 10207051 Free PMC article. - MDM2 and MDMX bind and stabilize the p53-related protein p73.
Ongkeko WM, Wang XQ, Siu WY, Lau AW, Yamashita K, Harris AL, Cox LS, Poon RY. Ongkeko WM, et al. Curr Biol. 1999 Jul 29-Aug 12;9(15):829-32. doi: 10.1016/s0960-9822(99)80367-4. Curr Biol. 1999. PMID: 10469568 - Comparative analysis of p73 and p53 regulation and effector functions.
Fang L, Lee SW, Aaronson SA. Fang L, et al. J Cell Biol. 1999 Nov 15;147(4):823-30. doi: 10.1083/jcb.147.4.823. J Cell Biol. 1999. PMID: 10562283 Free PMC article. - Regulation and activation of p53 and its family members.
Lohrum MA, Vousden KH. Lohrum MA, et al. Cell Death Differ. 1999 Dec;6(12):1162-8. doi: 10.1038/sj.cdd.4400625. Cell Death Differ. 1999. PMID: 10637431 Review. - MDM2: life without p53.
Daujat S, Neel H, Piette J. Daujat S, et al. Trends Genet. 2001 Aug;17(8):459-64. doi: 10.1016/s0168-9525(01)02369-1. Trends Genet. 2001. PMID: 11485818 Review.
Cited by
- Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer.
Adams CM, Mitra R, Xiao Y, Michener P, Palazzo J, Chao A, Gour J, Cassel J, Salvino JM, Eischen CM. Adams CM, et al. Cancer Discov. 2023 May 4;13(5):1210-1229. doi: 10.1158/2159-8290.CD-22-1131. Cancer Discov. 2023. PMID: 36734633 Free PMC article. - p53 Family in Resistance to Targeted Therapy of Melanoma.
Vlašić I, Horvat A, Tadijan A, Slade N. Vlašić I, et al. Int J Mol Sci. 2022 Dec 21;24(1):65. doi: 10.3390/ijms24010065. Int J Mol Sci. 2022. PMID: 36613518 Free PMC article. Review. - Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment.
Almeida J, Mota I, Skoda J, Sousa E, Cidade H, Saraiva L. Almeida J, et al. Cancers (Basel). 2022 Dec 16;14(24):6212. doi: 10.3390/cancers14246212. Cancers (Basel). 2022. PMID: 36551697 Free PMC article. Review. - Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry.
Guven-Maiorov E, Sakakibara N, Ponnamperuma RM, Dong K, Matar H, King KE, Weinberg WC. Guven-Maiorov E, et al. Mol Carcinog. 2022 Jul;61(7):629-642. doi: 10.1002/mc.23405. Epub 2022 May 13. Mol Carcinog. 2022. PMID: 35560453 Free PMC article. - Structural diversity of p63 and p73 isoforms.
Osterburg C, Dötsch V. Osterburg C, et al. Cell Death Differ. 2022 May;29(5):921-937. doi: 10.1038/s41418-022-00975-4. Epub 2022 Mar 21. Cell Death Differ. 2022. PMID: 35314772 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous